Concepedia

Imad Shureiqi

IS

Statistics

Publications

58

Citations

4.9K

H-Index

36

Active since

1999

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of Michigan

Applied Mathematics (United States)

The University of Texas at Austin

Imad Shureiqi is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and colorectal cancer.

Publications per year

1999–2023

58

Publications

58

<i>CCAT2</i>, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer

Hui Ling, Riccardo Spizzo, Yaser Atlasi et al. · Genome Research · 2013 · 611 citations · Full text

Medicine, Genetics, Oncology +17

<i>Fusobacterium</i> in Colonic Flora and Molecular Features of Colorectal Carcinoma

Tomomitsu Tahara, Eiichiro Yamamoto, Hiromu Suzuki et al. · Cancer Research · 2014 · 472 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Phase I Trial of Radiation Dose Escalation With Concurrent Weekly Full-Dose Gemcitabine in Patients With Advanced Pancreatic Cancer

Cornelius J. McGinn, Mark M. Zalupski, Imad Shureiqi et al. · Journal of Clinical Oncology · 2001 · 311 citations

Medicine, Oncology, Radiation Oncology +15

Lipoxygenase modulation to reverse carcinogenesis.

Imad Shureiqi, Scott M. Lippman · PubMed · 2001 · 269 citations

Medicine, Oncology, Pharmacology +15

The 15-lipoxygenase-1 product 13- <i>S</i> -hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells

Imad Shureiqi, Wei Jiang, Xiangsheng Zuo et al. · Proceedings of the National Academy of Sciences · 2003 · 238 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 58